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Abstract 45 
 46 
The role of brown adipose tissue (BAT) in pathological states of energy homeostasis and 47 
impaired adipocyte function, such as obesity has been a major area of research interest in 48 
recent years. Herein, we sought to determine the direct effects of adipokines, visfatin and 49 
leptin on BAT thermogenesis.   50 
The effects of mouse recombinant visfatin, nicotinamide mononucleotide (NMN) and leptin 51 
with or without FK866 were studied on differentiated T37i cells. Treated cells were 52 
analyzed for key genes and proteins regulating BAT [UCP-1, PRD1-BF1-RIZ1 homologous 53 
domain-containing 16 (PRDM-16), PPARgamma-coactivator-1alpha (PGC-1) and receptor-54 
interacting protein 140 (RIP-140)] using quantitative PCR and western blot analysis. Data is 55 
presented as mean P-values.  56 
Both visfatin and leptin had significant concentration dependent effects on thermogenesis 57 
in brown pre-adipocytes and at physiological levels, increased uncoupling protein-1 (UCP-1) 58 
levels in brown adipocytes. These effects of visfatin were similar to that of nicotinamide 59 
mononucleotide (NMN), further strengthening the enzymatic role of visfatin. We also 60 
showed that leptin induced UCP-1 mRNA expression and protein production appears to be 61 
mediated by visfatin. High concentrations of both visfatin and leptin led to a dramatic 62 
decrease in UCP-1 protein levels, supporting the notion that visfatin levels are raised in 63 
obesity and that obese people have reduced BAT activity, plausibly through a reduction in 64 
UCP-1 levels. Additionally, we found differential regulation of key brown adipogenic genes, 65 
specifically, PRD1-BF1-RIZ1 homologous domain-containing 16 (PRDM-16), PPARgamma-66 
coactivator-1alpha (PGC-1) and receptor-interacting protein 140 (RIP-140) by visfatin. 67 
Our observations provide novel insights in the potential actions of visfatin in BAT. 68 
 69 
 70 
Keywords: brown adipose tissue, obesity, thermogenesis, UCP-1, visfatin. 71 
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Highlights 72 
 Both visfatin and leptin have significant concentration dependent effects on 73 
thermogenesis in brown pre-adipocytes. 74 
 At physiological levels, both visfatin and leptin increased uncoupling protein-1 75 
(UCP-1) levels in brown adipocytes. 76 
 High concentrations of both visfatin and leptin decreased UCP-1 protein levels. 77 
 Our research suggests that visfatin levels are raised in obesity and that obese 78 
people have reduced BAT activity, plausibly through a reduction in UCP-1 levels. 79 
 80 
 81 
 82 
 83 
 84 
 85 
 86 
 87 
 88 
 89 
 90 
 91 
 92 
 93 
 94 
 95 
 96 
 97 
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1.1 Introduction 98 
Adipose tissue (AT) functions as a key energy metabolic regulator [1]. White adipose tissue 99 
(WAT) serves as an energy reservoir, whilst brown adipose tissue (BAT) is involved in β-100 
adrenergically mediated thermogenesis [2]. Recent studies have implicated the 101 
importance of this metabolic activity in BAT in states of insulin resistance and obesity 102 
(inversely correlated with body mass index and age) [3].  BAT has been regarded as a key 103 
target in developing anti-obesity treatment. Although stimulants of the adrenergic system 104 
are excellent agents for enhancing BAT activity, their use has been limited by harmful 105 
cardiovascular side-effects. A safer approach employing endogenous molecules, 106 
specifically, AT derived molecules (adipokines), as potential thermogenic agents 107 
stimulating BAT is currently under focus, being investigated extensively [4].  108 
 109 
Studies have elucidated the link between adipokines and AT function. Dysmetabolic states 110 
are characterized by altered circulating adipokine levels e.g. leptin and visfatin, levels of 111 
which are raised in obesity and metabolic syndrome, [5,6] influencing BAT function. 112 
Enriori et al. had demonstrated that central and peripheral administration of leptin 113 
significantly increased BAT energy expenditure via increased expression of mitochondrial 114 
uncoupling protein-1 (UCP-1) [7]. Other researchers have also demonstrated that in brown 115 
adipocytes undergoing differentiation, visfatin (intracellular and extracellular) levels are 116 
increased [8]. However, no studies have been to date conducted to elucidate the direct 117 
effects of visfatin (pre-B cell colony-enhancing factor or Nicotinamide 118 
phosphoribosyltransferase) a crucial energy regulator, on brown adipocytes. Moreover, we 119 
have previously demonstrated both in vivo and ex vivo regulation of visfatin production by 120 
leptin in WAT [9]. With this in mind, we sought to investigate the effects of leptin and 121 
visfatin in differentiated T37i cells , mitochondrial respiration and key genes involved in 122 
brown adipocyte energy regulation. 123 
 124 
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2.1 Materials and Methods 125 
We studied the effect of mouse recombinant visfatin (Axxora, Nottingham, UK), 126 
nicotinamide mononucleotide (NMN) (Sigma-Aldrich, Gillingham, UK)  and leptin 127 
(PeproTech, Rocky Hill, NJ, USA) with or without FK866 [a highly specific noncompetitive 128 
inhibitor of nicotinamide phosphoribosyltransferase (AxonChem, Groningen, Netherlands)] 129 
on differentiated T37i cells (a kind gift provided by Dr Marc Lombes, INSERM, Paris, France) 130 
cultured in standard DMEM:HAM’s F12 medium (Invitrogen, Paisley, UK) supplemented with 131 
10% fetal calf serum, 2mM glutamine, 100IU/ml penicillin, 100µg/ml streptomycin, 20mM 132 
HEPES and grown at 37°C in a humidified atmosphere with 5% CO2. Cells were 133 
differentiated with 2nM triiodothyronine (Sigma-Aldrich, Gillingham, UK) and 20nM insulin 134 
(Invitrogen, Paisley, UK) for 8 days [10,11]. The treated cells were analysed for key genes 135 
and proteins regulating BAT conversion [UCP-1, PRD1-BF1-RIZ1 homologous domain-136 
containing 16 (PRDM-16), PPARgamma-coactivator-1alpha (PGC-1) and receptor-137 
interacting protein 140 (RIP-140)] using quantitative PCR and Western blot analysis [12,13]. 138 
Isoproterenol (Sigma-Aldrich, Gillingham, UK) was used as a positive control in some 139 
experiments. Lipid accumulation was performed in these treated cells by using Oil Red O 140 
(Sigma-Aldrich, Gillingham, UK) staining (see Supplementary Information). 141 
 142 
2.1.1 Bioenergetic analysis of brown adipocytes 143 
The XF24 Extracellular/Flux Analyser (Seahorse Biosciences, North Billerica, MA, USA) was 144 
employed for bioenergetic analysis of T37i differentiated cells. All the chemicals required 145 
for these experiments were supplied by Seahorse Biosciences, North Billerica, MA, USA.  146 
The XF24 Extracellular/Flux Analyser measures oxygen consumption rate (OCR) in a 24-147 
well format by sensing changes in oxygen content (in a 7µl volume) above the plated cells 148 
with a fluorescence biosensor. T37i cells were seeded at a density of 3x104 149 
cells/well/500µl of Agilent Seahorse XF Assay Medium (Agilent Technologies)  in an 150 
extracellular flux 24-well cell culture plate and incubated at 37oC/5% Co2 for 8 days. At 151 
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the end of day 7, cells were stimulated with either visfatin (100ng/mL) or leptin (10-9M) or 152 
isoproterenol and cultured for a further 24 hours. Assays were initiated by removing the 153 
growth medium and replacing it with pre-warmed assay buffer medium. The microplates 154 
were incubated at 37oC for 30 minutes to equilibrate temperature and pH prior to OCR 155 
measurements. The XF24 microplate was then transferred to a temperature-controlled 156 
(37°C) Seahorse analyzer where it was subjected to a further 10-minute equilibration 157 
period and 4 assay cycles, each comprising a 1-minute mix, 2-minute wait and 3-minute 158 
measure period cycle. Following this, Oligomycin A (1µM) was added by automatic 159 
pneumatic injection to inhibit ATP synthase activity and thus approximate the proportion 160 
of respiration used to drive ATP synthesis (coupling efficiency). After 4 assay cycles, 161 
7.5μM carbonyl cyanide 4 trifluoromethoxy-phenylhydrazone (FCCP) was added.  Each 162 
experimental trace was ended following addition of oligomycin A (5μM) and rotenone 163 
(5μM). At the end of the incubation period, the plates were used to assess protein 164 
concentration in each well by BCA protein assay.  OCR (pmol/min) was normalised with 165 
protein content. 166 
 167 
2.1.2 T37i cell culture and differentiation 168 
T37i cells (a kind gift provided by Dr Marc Lombes, INSERM, Paris, France) were cultured in 169 
standard DMEM:HAM’s F12 medium (Invitrogen, Paisley, UK) supplemented with 10% fetal 170 
calf serum, 2mM glutamine, 100IU/ml penicillin, 100µg/ml streptomycin, 20mM HEPES and 171 
grown at 37°C in a humidified atmosphere with 5% CO2. Differentiation into mature brown 172 
adipocytes was achieved under standard conditions by incubating sub-confluent 173 
undifferentiated T37i cells with 2nM triiodothyronine [T3] (Sigma-Aldrich, Gillingham, UK)] 174 
and 20nM insulin (Invitrogen, Paisley, UK) for 8 days. At day 8 of differentiation, the cells 175 
were harvested for RNA (RT-PCR) and protein (Western blot). T37i cells were cultured in 176 
the presence of only differentiation stimuli (insulin + T3) for the control group and 177 
differentiation stimuli with or without visfatin (Axxora, Nottingham, UK), nicotinamide 178 
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mononucleotide (NMN) (Sigma-Aldrich, Gillingham, UK) or FK866 (AxonChem, Groningen, 179 
Netherlands) for the treatment group with two incubation time points as mentioned in the 180 
figure legend (Figure 1). Before stimulation, the differentiated cells were cultured 181 
overnight in the same media in the absence of serum. For UCP-1 mRNA expression and 182 
protein production studies, cells were incubated with media supplemented with 1µM 183 
isoproterenol for 6 hours prior to stimulation with peptides. The treated cells were 184 
analysed for key genes and proteins regulating brown adipose tissue conversion [UCP-1, 185 
PRD1-BF1-RIZ1 homologous domain-containing 16 (PRDM-16), PPARgamma-coactivator-186 
1alpha (PGC-1) and receptor-interacting protein 140 (RIP-140)] using quantitative RT-PCR 187 
and Western blot analysis.  188 
 189 
2.1.3 RNA Isolation and Real-Time Quantitative Reverse Transcription Polymerase 190 
Chain Reaction 191 
Total RNA was extracted using the QIAGEN RNeasy Mini Kit (Qiagen Ltd, West Sussex, UK), 192 
DNAse treated and reverse-transcribed into cDNA using a reverse transcription kit 193 
according to the manufacturer’s instructions (Fermentas Life Sciences, York, UK). The 194 
sequences for the sense and antisense primers (respectively) are listed in table 1. SYBR 195 
Green® real-time PCR was performed on a Biorad IQ5 realtime PCR (Bio-Rad, Hertfordshire, 196 
UK) using the primers listed above. PCR was performed using 2.5μl cDNA in 5.5μl PCR SYBR 197 
Green-1 Light Cycler Master Mix (Biogene, Cambridgeshire, UK), and 1μl each of sense and 198 
antisense primers (primer sequences as mentioned in table 1 below). A series of three 199 
dilutions for each cDNA was used to ensure linear amplification and to measure primer 200 
efficiency. Protocol conditions consisted of denaturation of 95oC for 60 secs, followed by 201 
40 cycles of 94oC for 1 sec, 60oC for 8 sec, and 72oC for 15 sec, followed by melting-curve 202 
analysis. For analysis, expression of genes of interest were normalised against the 203 
expression of the housekeeping gene GAPDH. Negative controls for all the reactions 204 
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included preparations lacking cDNA or RNA-lacking reverse transcriptase in place of the 205 
cDNA. The relative mRNA levels were expressed as a ratio using the "2-∆ct method" for 206 
comparing relative expression results between treatments in real-time PCR1. The PCR 207 
products from all samples were purified from the 1% agarose gel using the QIAquick Gel 208 
Extraction Kit (Qiagen Ltd, West Sussex, UK). PCR products were then sequenced in an 209 
automated DNA sequencer, and the sequence data were analyzed using Blast Nucleic Acid 210 
Database Searches from the National Centre for Biotechnology Information, confirming the 211 
identity of our products. 212 
Semi-quantitative PCR analysis was employed for the identification of long form of leptin 213 
receptor (Ob-Rb) in T37i cells. Following RNA extraction and cDNA conversion, using 214 
specific primers for Ob-Rb gene (mentioned in the table 1 below) PCR was carried out for 215 
40 cycles comprising of denaturation at 95° C for 1 min, annealing at 60° C for 30 sec, and 216 
extension at 72° C for 1 min. Amplification was terminated following a final extension step 217 
at 72 C for 10 min. PCR products were separated by agarose electrophoresis (1.5 % agarose 218 
gel), stained with ethidium bromide, and visualized under UV light.  219 
Table 1. List of genes and sequences for the sense and antisense primers 220 
Gene/product size (bp)           Sense primer      Antisense primer 
UCP-1 (83) 5′-ggcctctacgactcagtcca-3′ 5′- taagccggctgagatcttgt-3′ 
PRDM-16 (180) 5′- atgcgaggtctgccacaagt-3′ 5′- ctgccaggcgtgtaatggtt-3′ 
RIP-140 (173) 5′-tgcggatacttccacaggtc-3′ 5′-gcattcctcacagccaacag-3′ 
PGC-1 alpha (163) 5′- tgcagccaagactctgtatg-3′ 5′- attggtcgctacaccacttc-3′ 
GAPDH (185) 5′-gagtcaacggatttggtcgt-3′ 5′-gacaagcttcccgttctcag-3′ 
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Gene/product size (bp)           Sense primer      Antisense primer 
Ob-Rb (182)                       5′-aggcgcagcctgtattgtcc-3′ 5′-cacgttggtggcgagtcaag-3′ 
CtBP1 (171)                       5′-ttgggcatcattggactaggt-3′ 5′- taacgcagtcactgtggaaga-3′ 
CtBP2 (162)                       5′- atagaacgatctctgggcctg-3′ 5′- aatgcaccttgctctatctgc-3′ 
BMP-7 (99)                       5′- cttggctggcaggactggat-3′ 5′- gtctggacgatggcgtggtt-3′ 
       221 
2.1.4 Western Blot Analysis  222 
For UCP-1, PRDM-16 and BMP-7 protein analyses, following differentiation, T37i cells were 223 
incubated with media supplemented with 1µM isoproterenol for 6 hours prior to 224 
stimulation with only differentiation stimuli (insulin + T3) for the control group and 225 
differentiation stimuli [with or without visfatin, leptin, NMN or FK866] for the treatment 226 
group with various incubation time points as mentioned previously. Cells were then lysed 227 
with Laemmli buffer [5M urea, 0.17M SDS, 0.4M dithiothreitol and 50mM Tris-HCl (pH 228 
8.0)], mixed, sonicated, boiled, centrifuged (5,000rpm for 2 minutes), and stored at -80º C 229 
until use. Twenty micrograms of each sample were separated on a 10% Sodium Dodecyl 230 
Sulfate (SDS)-polyacrylamide gel, and electro-blotted onto a polyvinylidene fluoride 231 
(PVDF) membrane (Millipore, Bedford, MA, USA). The PVDF membrane was then incubated 232 
with 5% Bovine Serum Albumin (BSA) (Sigma-Aldrich, Gillingham, UK) in 1M Trizma/base, 233 
1.54M NaCl, 0.05% Tween 20 (Tris buffered solution plus Tween 20, TBST, pH 7.4) for one 234 
hour at room temperature, and then exposed overnight at 4°C to TBST containing UCP-1 235 
primary antibody [Abcam, Cambridge, UK (AB23841, dilution 1:1000)]. The membranes 236 
were then washed thoroughly for 60 min with TBS/0.1% Tween before incubation with 237 
anti-mouse secondary antibody, horseradish-peroxidase-conjugated Ig (1:2000) (Dako Ltd, 238 
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Cambridge, UK) for 1 hour at room temperature. Antibody complexes were visualized 239 
using chemiluminescence (ECL; GE Healthcare, Little Chalfont, UK). The densities were 240 
measured using a scanning densitometer coupled to scanning software ScionImage™ (Scion 241 
Corporation, Frederick, Maryland, USA). Standard curves were generated to ensure 242 
linearity of signal intensity over the range of protein amounts loaded into gel lanes. 243 
Comparisons of densitometric signal intensities for proteins of interest were made only 244 
within this linear range. 245 
 246 
2.1.5 Oil Red O stain 247 
As mentioned previously, T37i cells were differentiated with insulin and T3 for the control 248 
group and differentiation stimuli with or without visfatin, leptin, NMN or FK866 for the 249 
treatment group for 8 days. Following differentiation, the cells were washed with PBS and 250 
fixed with 10% formalin (Sigma-Aldrich, Gillingham, UK). This was followed by washes with 251 
distilled water and 60 % isopropanol (Sigma-Aldrich, Gillingham, UK). The cells were 252 
allowed to air dry, Oil Red O (Sigma-Aldrich, Gillingham, UK) working solution was added 253 
and incubated at room temperature for 10 minutes. The cells were washed 4 times with 254 
distilled water and images were acquired. 255 
 256 
2.1.6 Statistics  257 
Data were analyzed by Mann-Whitney U test or Friedman's ANOVA (post hoc analysis, 258 
Dunn's test) according to the number of groups compared. All statistical analyses were 259 
performed using SPSS version 18.0 (SPSS, Inc., Chicago, IL). P < 0.05 was considered 260 
significant. 261 
 262 
 263 
 264 
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3.1 Results 265 
Visfatin and leptin significantly increased UCP-1 mRNA and protein expression in 266 
differentiated T37i cells (Figures 1A-D). Visfatin (100ng/mL) showed the maximal response 267 
in contrary to visfatin (400ng/mL), which decreased UCP-1 levels. NMN (100µM) showed a 268 
comparable increase of UCP-1 levels to visfatin (100ng/mL). Pre-incubation of FK866 269 
(10µM) abolished visfatin (100ng/mL) induction of UCP-1 (Figures 1A-B). Leptin increased 270 
UCP-1 protein levels (maximal response at 10-9M), which was significantly negated by pre-271 
incubating with FK866 (10µM) (Figures 1C-D). Following differentiation protocol, T37i cells 272 
were serum starved for 12 hours and treated with or without visfatin (100, 200 and 273 
400ng/mL,), NMN (100µM) and FK866 (10µM) for two  time points (4 and 24 hours). Visfatin 274 
(100ng/mL) induced maximal expression of PRDM-16 mRNA at 4 hours. This effect of 275 
visfatin was not negated when pre-incubated with FK866 (10µM). NMN (100µM) induced a 276 
significant increase with comparable potency to visfatin (100ng/mL) (Figure 2A). 277 
Furthermore, PGC-1 mRNA expression was significantly increased in a concentration 278 
dependent manner by visfatin (maximal response at 400ng/mL). This effect was negated 279 
by pre-incubating FK866 (10µM). Once again, NMN (100µM) induced a significant increase 280 
with comparable potency to visfatin (400ng/mL) (Figure 2B). Also, visfatin (100ng/mL) 281 
significantly decreased RIP-140 mRNA expressions (Figure 2C). Interestingly, visfatin 282 
(400ng/mL), at 4 hours, resulted in a significant increase in RIP-140 mRNA expression. 283 
However, no effect was observed with NMN (100µM) treatment. Pre-incubation with FK866 284 
(10µM) resulted in a non-significant decrease of visfatin (400ng/mL) induced RIP-140 mRNA 285 
expression (Figure 2C). Leptin increased mRNA expression levels of PDRM-16 and PGC-1; 286 
however, similar to visfatin, the maximal response dose of leptin i.e. 10-9M, decreased 287 
RIP-140 mRNA expression levels (data not shown). Following differentiation protocol, T37i 288 
cells were serum starved overnight, and treated with or without leptin (10-7, 10-9 and 10-289 
11M) for various time points (4-24 hours - data not shown). Leptin significantly increased 290 
mRNA expression and protein production of visfatin (Maximal response was at 4 hours and 291 
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leptin 10-7M) (Figures 4A-B). Finally, functional assays showed that visfatin (100ng/mL) 292 
caused a significant increase in lipid accumulation (Oil Red O stain) in pre-adipocytes and 293 
oxygen consumption (mitochondrial respiration) in mature brown adipocytes (Figures 1E-F). 294 
3.1.2 Visfatin induces visfatin mRNA expression levels of brown adipogenic genes- 295 
CtBP-1, CtBP-2 and BMP-7. 296 
In order to evaluate overall visfatin induced effects in brown adipogenesis, we sought to 297 
determine the effects of visfatin on key genes including CtBP-1 (C-terminal-binding 298 
protein 1), CtBP-2 and BMP-7 (Bone morphogenetic protein 7). Visfatin (400ng/mL) showed 299 
the maximal response in up-regulating all three genes, comparable with NMN (100µM). 300 
However, it is interesting to note that pre-incubation of FK866 (10µM) abolished visfatin 301 
(400ng/mL) induced CtBP-1 and BMP-7 mRNA expression levels (Fig-2D and Fig-2F), failed 302 
to do so with CtBP-2 mRNA expression (Fig-2E) 303 
3.1.3 Visfatin increases protein expression levels of BMP-7 and PRDM-16 in 304 
differentiated T37i cells. 305 
Visfatin concentration dependently increased protein expression levels of BMP-7 at 24 306 
hours, promptly decreased by pre-incubation with FK-866. This increase induced by 307 
visfatin (400ng/mL) was comparable to the effects of NMN (100uM) (Fig-3A). However, in 308 
contrary, visfatin (100ng/mL) showed a significant increase in PRDM-16 protein levels and 309 
pre-incubation with FK-866 did not cause any significant effect (Fig-3C). To further study 310 
the concentration dependent effects of visfatin on protein expression levels of PRDM-16, 311 
we employed additional doses of 10, 25 and 50ng/mL of visfatin. The maximal response 312 
was observed at 100ng/mL of visfatin (Fig-3B). 313 
 314 
 315 
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3.1.4 Leptin induces visfatin mRNA and protein expression levels in a concentration 316 
dependent manner. 317 
We used leptin in concentration ranges of 10-7 – 10-11 M in accordance with studies by 318 
others [14,15], to include physiological and pathological concentrations [2,3]. Leptin 319 
increased visfatin mRNA expression and protein expression levels in T37i cells 320 
concentration dependently with a maximum response at leptin 10−7 M (Fig.4A and 4B). 321 
 322 
3.1.5 Identification of Ob-Rb receptor in T37i cells and mouse BAT 323 
We employed RT-PCR analysis and gene specific primers to validate the presence of Ob-Rb 324 
gene in T37i cells and BAT (Fig.5) in line with previous reports [4]. 325 
 326 
 327 
4.1 Discussion 328 
We present novel data indicating that visfatin significantly increased oxygen consumption 329 
(mitochondrial respiration) and lipid accumulation in differentiated T37i cells  . 330 
Furthermore, visfatin, at physiological levels, significantly increased UCP-1 and PDRM-16 331 
and decreased RIP-140 levels in T37i cells. Interestingly, FK-866 had no effect on visfatin 332 
induced PDRM-16 up-regulation. This may be due to the involvement of an undefined 333 
visfatin receptor. Also, this may be explained by the observation that eNampt (visfatin) 334 
blocks macrophage apoptosis through activation of IL-6/STAT3 pathway. This effect was 335 
not blocked by FK866, suggesting a non-enzymatic mechanism of action [16]. Moreover, 336 
like others, [7] we found that leptin significantly increased oxygen consumption and 337 
significantly increased UCP-1 levels in T37i cells . Interestingly, higher concentrations of 338 
leptin resulted in a significant decrease in UCP-1 levels in T37i cells. Importantly, we 339 
showed that leptin induced UCP-1 mRNA expression and protein production appears to be 340 
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mediated by visfatin. UCP-1 drives BAT thermogenesis, PDRM-16 promotes brown 341 
adipogenesis and BAT thermogenesis via increased stimulation of UCP-1 [17] whereas RIP-342 
140 is an important co-repressor and inhibitor of brown adipogenesis and BAT 343 
thermogenesis [18]. However, higher concentrations of visfatin had opposite effects. This 344 
supports the observations that visfatin levels are raised in obesity [5] and that obese 345 
people have reduced BAT activity, [19] plausibly through a reduction in UCP-1 levels. 346 
Others were able to demonstrate that visfatin was preferentially expressed in mature 347 
adipocytes and that this expression was higher in brown adipose tissue of rodents 348 
compared to other fat depots following biopsies [20]. The situation was different in obese 349 
humans where visfatin expression was found to be equivalent between white and brown or 350 
brite adipocytes in vivo and in vitro supporting that BAT thermogenic properties are 351 
blunted during obesity [20]. Interestingly, we also found that visfatin concentration 352 
dependently increased PGC-1 (a strong inducer of UCP-1) mRNA expression in T37i cells. 353 
PGC-1 promotes BAT thermogenesis but not brown adipogenesis [21]; additionally, we 354 
elucidated PGC-1 independent UCP-1 gene induction. Studies have implicated a 355 
hyperglycemic state of impaired glucose metabolism induced by PGC-1 inhibiting insulin 356 
signaling and glucose utilization [22]. Taken together; our novel findings potentially 357 
suggest  that visfatin could induce insulin resistance in dysmetabolic states such as obesity 358 
and diabetes via PGC-1 without a marked change in UCP-1 levels. However, further 359 
studies are required in brown adipocytes and in vivo. 360 
 361 
4.2 Conclusion 362 
In conclusion, our significant observations provide novel insights with respect to the 363 
potential actions of visfatin in brown adipocytes using T37i cell line. Future in vivo 364 
research should also seek to clarify whether visfatin could moderate thermogenesis and 365 
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adipogenesis, and whether it would be beneficial in the management of obesity and its 366 
dysmetabolic sequelae. 367 
 368 
5.1 Declaration of Interest 369 
The authors declare no conflict of interest that could be perceived as prejudicing the 370 
impartiality of the research reported. 371 
 372 
6.1 Funding  373 
This research did not receive any specific grant from any funding agency in the public, 374 
commercial or not-for-profit sector. 375 
 376 
7.1 Acknowledgements 377 
Dr Marc Lombes, INSERM, Paris, France kindly provided the T37i cells. HSR would like to 378 
acknowledge S. Waheguru, University of Warwick for his continual support. 379 
 380 
8.1 References 381 
[1] Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 382 
2004; 89: 2548-2556. 383 
[2] Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. 384 
Physiol Rev 2004; 84: 277-359. 385 
[3] Cypess AM, et al. Identification and importance of brown adipose tissue in adult 386 
humans. N Engl J Med 2009; 360: 1509-1517.  387 
[4] Whittle AJ, López M, Vidal-Puig A. Using brown adipose tissue to treat obesity - the 388 
central issue. Trends Mol Med 2011; 17: 405-411. 389 
[5] Berndt J, et al. Plasma visfatin concentrations and fat depot-specific mRNA expression 390 
in humans. Diabetes 2005; 54: 2911-2916. 391 
16 
 
[6] van Dielen FM, van’t Veer C, Buurman WA, Greve JW. Leptin and soluble leptin 392 
receptor levels in obese and weight-losing individuals. J Clin Endocrinol Metab 2002; 87: 393 
1708-1716. 394 
[7] Enriori PJ, Sinnayah P, Rudaz CG, Cowley MA. Leptin Action in the Dorsomedial 395 
Hypothalamus Increases Sympathetic Tone to Brown Adipose Tissue in Spite of Systemic 396 
Leptin Resistance. J Neurosci 2011; 31: 12189-12197. 397 
[8] Revollo JR, et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a 398 
systemic NAD biosynthetic enzyme. Cell Metab 2007; 6: 363-375. 399 
[9] Tan BK, et al. In vivo and ex vivo regulation of visfatin production by leptin in human 400 
and murine adipose tissue: role of mitogen-activated protein kinase and 401 
phosphatidylinositol 3-kinase signaling pathways. Endocrinology 2009; 150: 3530-3539. 402 
[10] Viengchareun S, Penfornis P, Zennaro MC, Lombès M. Mineralocorticoid and 403 
glucocorticoid receptors inhibit UCP expression and function in brown adipocytes. Am J 404 
Physiol Endocrinol Metab. 2001 Apr;280(4):E640-9. 405 
[11] Kuhn E, Lombès M. The mineralocorticoid receptor: a new player controlling energy 406 
homeostasis. Horm Mol Biol Clin Investig. 2013 Sep;15(2):59-69. doi: 10.1515/hmbci-2013-407 
0033. Review. 408 
[12] Richard D, Picard F. Brown fat biology and thermogenesis. Front Biosci (Landmark Ed). 409 
2011 Jan 1;16:1233-60. 410 
[13] Whittle AJ, et al. BMP8B increases brown adipose tissue thermogenesis through both 411 
central and peripheral actions. Cell. 2012 May 11;149(4):871-85. doi: 412 
10.1016/j.cell.2012.02.066. 413 
[14] Mahabir S, et al. Body Mass Index, percent body fat, and regional body fat distribution 414 
in relation to leptin concentrations in healthy, non-smoking postmenopausal women in a 415 
feeding study. Nutr J. 2007 Jan 17;6:3. 416 
[15] Hwa JJ, et al. Leptin increases energy expenditure and selectively promotes fat 417 
metabolism in ob/ob mice. Am J Physiol. 1997 Apr;272(4 Pt 2):R1204-9. 418 
17 
 
[16] Li Y, et al. Extracellular Nampt promotes macrophage survival via a nonenzymatic 419 
interleukin-6/STAT3 signaling mechanism. J Biol Chem. 2008; 283(50):34833-43. 420 
[17] Seale P, et al. Transcriptional control of brown fat determination by PRDM16. Cell 421 
Metab 2007; 6: 38-54. 422 
[18] Christian M, Kiskinis E, Debevec D, Leonardsson G, White R, Parker M.G. RIP140-423 
targeted repression of gene expression in adipocytes. Mol Cell Biol 2005; 25: 9383-9391. 424 
[19] Vijgen GH, Bouvy ND, Teule GJ, Brans B, Schrauwen P, van Marken Lichtenbelt WD. 425 
Brown Adipose Tissue in Morbidly Obese Subjects. PLoS One 2011; 6: e17247. 426 
[20] Pisani DF et al. Visfatin expression analysis in association with recruitment and 427 
activation of human and rodent brown and brite adipocytes. Adipocyte. 2015 Dec 428 
9;5(2):186-95. 429 
[21] Uldry M, Yang W, St-Pierre J, Lin J, Seale P, Spiegelman BM. Complementary action of 430 
the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation. Cell 431 
Metab 2006; 3: 333-341. 432 
[22] Wende AR, Huss JM, Schaeffer PJ, Giguère V, Kelly DP. PGC-1alpha coactivates PDK4 433 
gene expression via the orphan nuclear receptor ERRalpha: a mechanism for 434 
transcriptional control of muscle glucose metabolism. Mol Cell Biol 2005; 25: 10684-10694. 435 
 436 
 437 
Figure Legends 438 
 439 
Figure 1.  Serum-starved differentiated T37i cells were pre-incubated with or without 440 
FK866 (10uM). On treatment with or without visfatin (100-400ng/mL) or NMN (100uM) or 441 
isoproterenol (1µM) for 4 hours, mRNA levels of (A) UCP-1 was analyzed by real-time PCR 442 
and normalized with the housekeeping gene GAPDH. Similarly, serum-starved 443 
differentiated T37i cells were treated for 24 hours, protein expression levels of (B) UCP-1 444 
was analyzed by western blot analyses and densitometric analyses of UCP-1, normalized to 445 
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β-actin and expressed as a fold increase over basal.  Experiments were performed in 446 
triplicates. The values represented are relative to basal.  **P < 0.01, *P < 0.05 vs. basal, #P 447 
< 0.01 vs. visfatin (100ng/mL) only treated, n = 6 per group. Likewise, serum-starved 448 
differentiated T37i cells were pre-incubated with or without FK866 (10uM). On treatment 449 
with or without leptin (10-11, 10-9 and 10-7 M) or isoproterenol (1µM) for 4 hours, mRNA 450 
levels of (C) UCP-1 was analyzed by real-time PCR and normalized with the housekeeping 451 
gene GAPDH. Similarly, serum-starved differentiated T37i cells were treated for 24 hours, 452 
protein expression levels of (D) UCP-1 was analyzed by western blot analyses and 453 
densitometric analyses of UCP-1, normalized to β-actin and expressed as a fold increase 454 
over basal. Experiments were performed in triplicates.  The values represented are 455 
relative to basal. ***P < 0.001, **P < 0.01, *P < 0.05 vs. basal, #P < 0.01 vs. leptin (10-9 M) 456 
only treated n = 6 per group. 457 
T37i cells were differentiated with insulin and T3 (6 days) for control group and 458 
differentiation stimuli with or without visfatin (100-400ng/mL) or NMN (100uM) or leptin 459 
(10-11, 10-9 and 10-7 M) for treatment group for 2 days. One set of treatment group was pre-460 
incubated with FK866 (10 uM). (E) Representative scanned images of Oil Red O stained 461 
brown adipocytes [1] and [2] Control (undifferentiated) [3] Control (differentiated) [4] 462 
Visfatin(100ng/mL) [5] Vis(100ng/mL)+FK866(10µM) [6] NMN(100µM).(F) Mitochondrial 463 
respiration [oxygen consumption rate (OCR)] in differentiated brown adipocytes (day 6) 464 
was assessed using the XF24 Extracellular/Flux Analyser. A representative graph of the 465 
OCRs of untreated, visfatin, leptin and isoproterenol treated cells in their basal states and 466 
on treatment with oligomycin, FCCP and rotenone used to demonstrate the specific 467 
components of the respiratory chain. Experiments were performed in triplicates.  The 468 
values represented are relative to basal. **P < 0.01, *P < 0.05 vs. untreated cells (control 469 
of that particular group), n = 6 per group. 470 
 471 
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Figure 2. Serum-starved differentiated T37i cells were pre-incubated with or without 472 
FK866 (10uM). On treatment with or without visfatin (100-400ng/mL) or NMN (100uM) for 4 473 
hours, mRNA levels of (A) PDRM-16, (B) PGC-1, (C) RIP-140, (E) CtBP-1, (F) CtBP-2 and (G) 474 
BMP-7 were analyzed by real-time PCR and normalized with the housekeeping gene GAPDH. 475 
Experiments were performed in triplicates.  The values represented are relative to basal. 476 
***P < 0.001, **P < 0.01, *P < 0.05 vs. basal, #P < 0.01 vs. visfatin (100 or 400ng/mL) only 477 
treated, NS- Non-Significant vs. basal, n = 6 per group. 478 
Figure 3. Serum-starved differentiated T37i cells were pre-incubated with or without 479 
FK866 (10uM). On treatment with or without visfatin (100-400ng/mL) or NMN (100uM) for 480 
24 hours, protein levels of (A) BMP-7 and (C) PRDM-16 were analyzed by western blot 481 
analyses and normalized with the housekeeping protein GAPDH.  Similar experiments were 482 
performed with concentration dependent visfatin (10, 25, 50 and 100 ng.mL) for 24 hours 483 
and protein levels of (B) PRDM-16 were analyzed by western blot analyses and normalized 484 
with the housekeeping protein GAPDH. Experiments were performed in triplicates.  The 485 
values represented are relative to basal. ***P < 0.001, **P < 0.01, *P < 0.05 vs. basal, #P < 486 
0.01 vs. visfatin (100 or 400ng/mL) only treated, NS- Non-Significant vs. basal, n = 6 per 487 
group. 488 
Figure 4. Following time optimisation studies, serum-starved differentiated T37i cells 489 
were treated with or without leptin (10-11, 10-9 and 10-7 M) for 4 hours; (A) mRNA levels of 490 
visfatin were analyzed by real-time PCR and normalized with the housekeeping gene 491 
GAPDH. Experiments were performed in triplicates. The values represented are relative to 492 
basal. ***P < 0.001, **P < 0.01, *P < 0.05 vs. basal, n = 6 per group. Similar treatments 493 
were done with leptin for 24 hours, (B) protein expression levels of visfatin were analyzed 494 
by western blot and densitometric analyses normalized to β-actin and expressed as a fold 495 
increase over basal. Experiments were performed in triplicates.  The values represented 496 
are relative to basal. ***P < 0.001, **P < 0.01, *P < 0.05 vs. basal, n = 6 per group. 497 
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Figure 5.  RT-PCR amplification of Ob-Rb gene. Lane 1, DNA ladder marker; lane 2, cDNA 498 
from T37i cells; lane 3, cDNA from mouse BAT; lane 4, -ve control (RT –ve – cDNA 499 
preparation lacking reverse transcriptase). 500 
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